MRNY vs. MRNA
Compare and contrast key facts about YieldMax MRNA Option Income Strategy ETF (MRNY) and Moderna, Inc. (MRNA).
MRNY is an actively managed fund by YieldMax. It was launched on Oct 23, 2023.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MRNY or MRNA.
Key characteristics
| MRNY | MRNA | |
|---|---|---|
| YTD Return | -58.02% | -57.01% |
| 1Y Return | -44.04% | -38.97% |
| Sharpe Ratio | -0.97 | -0.66 |
| Sortino Ratio | -1.27 | -0.75 |
| Omega Ratio | 0.82 | 0.91 |
| Calmar Ratio | -0.66 | -0.42 |
| Martin Ratio | -1.45 | -1.13 |
| Ulcer Index | 29.95% | 34.15% |
| Daily Std Dev | 44.94% | 58.56% |
| Max Drawdown | -66.20% | -91.18% |
| Current Drawdown | -66.20% | -91.18% |
Correlation
The correlation between MRNY and MRNA is 0.96, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
MRNY vs. MRNA - Performance Comparison
The year-to-date returns for both investments are quite close, with MRNY having a -58.02% return and MRNA slightly higher at -57.01%. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MRNY vs. MRNA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for YieldMax MRNA Option Income Strategy ETF (MRNY) and Moderna, Inc. (MRNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
MRNY vs. MRNA - Dividend Comparison
MRNY's dividend yield for the trailing twelve months is around 169.25%, while MRNA has not paid dividends to shareholders.
| TTM | 2023 | |
|---|---|---|
MRNY YieldMax MRNA Option Income Strategy ETF | 169.25% | 1.75% |
MRNA Moderna, Inc. | 0.00% | 0.00% |
Drawdowns
MRNY vs. MRNA - Drawdown Comparison
The maximum MRNY drawdown since its inception was -66.20%, smaller than the maximum MRNA drawdown of -91.18%. Use the drawdown chart below to compare losses from any high point for MRNY and MRNA. For additional features, visit the drawdowns tool.
Volatility
MRNY vs. MRNA - Volatility Comparison
The current volatility for YieldMax MRNA Option Income Strategy ETF (MRNY) is 11.24%, while Moderna, Inc. (MRNA) has a volatility of 12.51%. This indicates that MRNY experiences smaller price fluctuations and is considered to be less risky than MRNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.